DMRA
Damora Therapeutics, Inc.
20.70$
-0.4%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | |
| – | – | +69.4% | +134.6% | +11.1% | +69.4% | -78.2% | -81.2% | |
| – | – | – | – | – | – | – | – | |
| – | +261.9% | -32.6% | +56.3% | +25.2% | -50.7% | -73.1% | +3,044.5% | |
| – | – | – | – | -5.4% | -2.4% | -17.2% | -7.8% | |
| – | +201.1% | -13.9% | +54.8% | +17.2% | -41.3% | -53.1% | +1,161.5% | |
| – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | +22.0% | |
| – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.